VivoSeq
Other

Wound

0

Pipeline Programs

6

Active Trials

3

Companies Involved

Wound is an early-stage landscape with 0 programs across 3 companies. The most active players are Laboratorios Ozoaqua, Imbed Biosciences, MolecuLight Inc..

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

21

clinical trials

Completed9 · 43%
Unknown status4 · 19%
Not yet recruiting4 · 19%
Terminated2 · 10%
Recruiting1 · 5%
Enrolling by invitation1 · 5%

Trial Activity

21 trials

Vashe Wound Therapy Study
Completed·VValleywise Health·N/A·NCT00586729·23 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)